109145 ⎘
Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.
Method of treating delayed healing of a wound associated with diabetes
#3902Methods and compositions relating to proteasome inhibitor resistance
#3903Methods and compositions for the activation of gamma-delta T-cells
#3904PARENTAL RNAI SUPPRESSION OF CHROMATIN REMODELING GENES TO CONTROL COLEOPTERAN PESTS
#3905Transgenic plant of the species with resistance to
#3906Pharmaceutical composition for preventing and treating metabolic disease comprising MKRN1 expression or activity inhibitor as an active ingredient
#3907METHODS AND COMPOSITIONS FOR PREVENTING ISCHEMIA REPERFUSION INJURY IN ORGANS
#3908PARENTAL RNAI SUPPRESSION OF HUNCHBACK GENE TO CONTROL HEMIPTERAN PESTS
#3909Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
#3910SARNA COMPOSITIONS AND METHODS OF USE
#3911Polypeptides having beta-xylosidase activity and polynucleotides encoding same
#3912Method and System for Monitoring Nutritional Uptake as a Function of Hydrogen Gas Levels
#3913COMPOSITIONS AND METHODS FOR PRESERVING CELLS OF THE EYE
#3914NUCLEIC ACID-LIPOPOLYMER COMPOSITIONS
#3915POLYNUCLEOTIDES HAVING BIOREVERSIBLE GROUPS
#3916Method of preventing or treating osteoporosis by neddylation inhibitor
#3917Methods and tools for Vel blood group typing
#3918METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#3919METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#3920CYTOTOXIC T CELL RESPONSE MODIFIERS
#3921Genetic variations associated with drug resistance
#3922Methods and compositions involving transmembrane and coiled-coil domains 3 (TM-CO3) in cancer
#3923Non-coding RNAs linked to immortality and associated methods and compositions
#3924SMALL INTERFERING RNA MODIFICATION METHOD BY COMBINING WITH ISONUCLEOSIDE MODIFICATION, TERMINAL PEPTIDE CONJUGATION AND CATIONIC LIPOSOMES, AND PREPARATION
#3925METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH17 MEDIATED DISEASES
#3926Compounds for targeting drug delivery and enhancing siRNA activity
#3927TARGETED THERAPEUTIC NUCLEOSIDES AND THEIR USE
#3928Lipids and lipid compositions for the delivery of active agents
#3929Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate
#3930Method of treating cancer with compositions comprising IL-31
#3931Compositions for treating heart disease by inhibiting the action of mAKAP-β
#3932Treatment targeting oncology and neurodegeneration
#3933Interfering RNA molecules
#3934USP30 INHIBITORS AND METHODS OF USE
#3935Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#3936METHODS AND COMPOSITIONS FOR PROMOTING HAIR GROWTH
#3937Blood Brain Barrier Opening Agents and Uses Thereof
#3938ETS factors regulate neural stem cell depletion and gliogenesis in Ras pathway glioma
#3939USE OF THERAPEUTIC AGENTS
#3940Micelle composition for nucleic acid delivery using temperature-sensitive polymer and method for producing same
#3941Treatment and diagnosis of immune disorders
#3942Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3943PRE-MRNA PROCESSING FACTOR 19 (PRP19) NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS
#3944Methods and compositions for the treatment of head and neck cancer
#3945Therapeutic agent for sarcopenia and metabolic diseases
#3946Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
#3947Oligonucleotides for modulating gene expression and uses thereof
#3948ORGANIC COMPOSITIONS TO TREAT BETA-CATENIN-RELATED DISEASES
#3949Plant-mediated silencing of a fatty acid and retinoid binding protein in
#3950Lipid formulated compositions and methods for inhibiting expression of Serum Amyloid A gene
#3951Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA
#3952Expression of Fc-containing proteins
#3953FALZ for use as a target for therapies to treat cancer
#3954Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereof
#3955Methods and compositions for the production of siRNAs
#3956RNAi CONJUGATES, PARTICLES AND FORMULATIONS THEREOF
#3957Programmed cell death 1 ligand 1 (PD-L1) iRNA compositions and methods of use thereof
#3958MODULATION OF TRANSTHYRETIN EXPRESSION
#3959Compounds and methods for modulation of DUX4
#3960Methods and compositions related to increased influenza virus production
#3961LIN28- MEDIATED CONTROL OF LET-7 BIOGENESIS
#3962Methods and compositions for treatment of atherosclerosis
#3963Biodegradable lipids for delivery of nucleic acids
#3964Biodegradable lipids for delivery of nucleic acids
#3965Biodegradable lipids for delivery of nucleic acids
#3966Biodegradable lipids for delivery of nucleic acids
#3967METHODS FOR TREATING AND/OR PREVENTING A TUMOR GROWTH, INVASION AND/OR METASTASIS
#3968Amphiphilic dendrimers complexed with siRNA for treatment of cancer
#3969RIBOSOMAL NUCLEIC ACID MOLECULES TO CONTROL INSECT PESTS
#3970AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
#3971Short interfering nucleic acid (siNA) molecules containing a 2′ internucleoside linkage (3dT)
#3972METHODS AND COMPOSITIONS COMPRISING APSE KNOTS
#3973NUCLEIC ACID MOLECULES WITH ENHANCED ACTIVITY
#3974Polypeptides, nucleic acids and uses thereof
#3975Method effective to modulate expression of T-box protein 4 (Tbx4) for reducing progression of lung fibrosis after a lung injury
#3976METHODS FOR THE TREATMENT OF ALOPECIA AREATA UTILIZING GENE MODULATION APPROACHES
#3977COMPOSITIONS AND METHODS FOR CREATING PANCREATIC CANCER ANIMAL MODEL
#3978Pharmaceutical composition for treating or preventing obesity
#3979BIOMARKERS ASSOCIATED WITH BRM INHIBITION
#3980Cannabis plants having modified expression of THCA synthase
#3981Compositions and Methods for Inhibiting Gene Expression of Alpha-1 AntiTrypsin
#3982SARNA COMPOSITIONS AND METHODS OF USE
#3983Modified iRNA agents
#3984Compounds for inducing anti-tumor immunity and methods thereof
#3985Method of making trabecular bone
#3986Methods and compositions for promoting survival and proliferation of endothelial cells and stimulating angiogenesis
#3987Compositions and methods for modulating FMR1 expression
#3988Conjugated antisense compounds and their use
#3989Hydrogels for delivery of therapeutic compounds
#3990MUTANT CALRETICULIN FOR THE DIAGNOSIS OF MYELOID MALIGNANCIES
#3991Increasing plant oil content by altering a negative regulator of acetyl-coa carboxylase
#3992Compositions and Methods for Inducing Senescence in Cancer Cells
#3993Use of trinucleotide repeat RNAs to treat cancer
#3994Compositions and methods for differentiation of human pluripotent stem cells into desired cell types
#3995COLON DISEASE TARGETS AND USES THEREOF
#3996MODIFIED POLY (BETA-AMINO ESTER)S FOR DRUG DELIVERY
#3997Compositions and methods for inhibiting expression of ADAMTS-5 and ADAM17
#3998Methods for detection of RNase activity
#3999Methods and compositions for determining pH
#4000RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
#4001PARENTAL RNAI SUPPRESSION OF CHROMATIN REMODELING GENES TO CONTROL COLEOPTERAN PESTS
#4002Methods and compositions for altering function and structure of chromatin loops and/or domains
#4003COMPOSITIONS AND METHODS FOR TREATING HYPERTRIGLYCERIDEMIA
#4004METHODS AND COMPOSITIONS FOR ENHANCING GENE EDITING
#4005Methods of expanding hematopoietic stem cells, compositions, and methods of use thereof
#4006Anti-PVRIG antibodies and methods of use
#4007THERAPEUTIC CELL INTERNALIZING CONJUGATES
#4008Block copolymers
#4009Compounds and methods for trans-membrane delivery of molecules
#4010Stabilization method of functional nucleic acid
#4011METHOD OF DIAGNOSING, TREATING AND DETERMINING PROGRESSION AND SURVIVAL OF CANCER CELLS USING BCL-2 ANTAGONIST OF CELL DEATH (BAD) PATHWAY GENE SIGNATURE
#4012Notch 1 specific siRNA molecule
#4013Compositions and methods for regulation of gene expression with, and detection of, folinic acid and folates
#4014UNA oligomers for therapeutics with prolonged stability
#4015EXOSOME TRANSFER OF NUCLEIC ACIDS TO CELLS
#4016Compositions and methods of using anti-mullerian hormone for treatment of infertility
#4017Reagents and Methods for miRNA Expression Analysis and Identification of Cancer Biomarkers
#4018Method for expression of small RNA molecules within a cell
#4019Methods of identifying and treating poor-prognosis cancers
#4020Compositions and methods for inhibiting gene expression of Hif2alpha
#4021Method of treating pain with an antibody against netrin-4, UNC5B or neogenin
#4022Notch inhibition in the treatment and prevention of nonalcoholic fatty liver disease
#4023METHOD OF TREATING AND PROGNOSING SCOLIOTIC PATIENT SUBGROUPS
#4024COPI COATOMER GAMMA SUBUNIT NUCLEIC ACID MOLECULES THAT CONFER RESISTANCE TO COLEOPTERAN AND HEMIPTERAN PESTS
#4025COMPOSITIONS AND METHODS FOR THE MODULATION OF DNA DAMAGE RESPONSES USING BAL1 AND BBAP
#4026Fibrotic treatment
#4027Interfering RNA molecules
#4028Multimeric oligonucleotides having decreased kidney clearance
#4029Compositions and methods for treating leukemia
#4030SITE-SPECIFIC DELIVERY OF NUCLEIC ACIDS BY COMBINING TARGETING LIGANDS WITH ENDOSOMOLYTIC COMPONENTS
#4031Agents for use in the treatment of glioma
#4032Treatments of oxidative stress conditions
#4033Compositions and methods for modulating ABHD2 activity
#4034Nucleic acid molecules that control pathogens
#4035Compositions and methods for inhibiting expression of the PCSK9 gene
#4036XANTHINE DEHYDROGENASE (XDH) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
#4037METHODS FOR REDUCING PROTEOTOXICITY
#4038PROCESS FOR INDUCING RESISTANCE TO DIPHTHERIA TOXIN IN HUMAN CELLS, PRODUCTS AND USES THEREOF
#4039Paratransgenic system for the biocontrol of disease-transmitting mosquitos
#4040Biological control of coleopteran pests
#4041HSD17B13 variants and uses thereof
#4042HSD17B13 variants and uses thereof
#4043Sustained polypeptide expression from synthetic, modified RNAs and uses thereof
#4044Regulatory Protein Deficient Trichoderma Cells and Methods of Use Thereof
#4045MODULATION OF SRPX2-MEDIATED ANGIOGENESIS
#4046Methods and compositions for selecting siRNA of improved functionality
#4047SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS
#4048COMPOSITIONS AND METHODS FOR SILENCING HEPATITIS B VIRUS GENE EXPRESSION
#4049Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4050TREATMENT OF LIPID TRANSPORT AND METABOLISM GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A LIPID TRANSPORT AND METABOLISM GENE
#4051Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
#4052Multi-targeted single entity conjugates
#4053Generation of airway epithelial organoids from human pluripotent stem cells
#4054Method of synthesis of an ionizable cationic lipid
#4055Method of modulating a chimeric antigen receptor t cell immune response by administering IL-10
#4056OLIGONUCLEOTIDE DERIVATIVE
#4057PHARMACEUTICAL COMPOSITIONS COMPRISING DANIRIXIN FOR TREATING INFECTIOUS DISEASES
#4058Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFLD)
#4059Methods of treating pain using anti-GPR160 antibodies
#4060Fidgetin-like 2 as a target to enhance wound healing
#4061Methods and compositions for selecting siRNA of improved functionality
#4062Compounds for inducing anti-tumor immunity and methods thereof
#4063Treatment of adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an adiponectin (ADIPOQ)
#4064Insulin-like growth factor binding protein, acid labile subunit (IGFALS) compositions and methods of use thereof
#4065Micromirs
#4066NOVEL PRECURSOR MIRNA AND APPLICATION THEREOF IN TUMOR TREATMENT
#4067METHODS AND COMPOSITIONS FOR MODULATING LILR PROTEINS
#4068Isolated antibodies against interleukin-17 receptor B (IL-17RB) for cancer therapy
#4069ANTI-ANGIOGENIC VEGF-AX ISOFORM
#4070Control of coleopteran pests using RNA molecules
#4071PEST CONTROL SYSTEM
#4072Methods of treating brain edema
#4073Compositions and methods for inhibiting expression of RRM2 genes
#4074Glucokinase (GCK) iRNA compositions and methods of use thereof
#4075Nucleic acid molecules targeting superoxide dismutase 1 (SOD1)
#4076RNA interference mediated inhibition of hepatitis B Virus (HBV) gene expression using short interfering nucleic acid (siNA)
#4077Compositions and methods for inhibiting gene expression of LPA
#4078Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
#4079Methods for treating apolipoprotein E4-associated disorders
#4080Transgenic microalgae and use thereof as a feed for delivery of interfering RNA molecules
#4081Therapeutic agent for a lung disease and/or method for screening for the same
#4082DISCONTINUOUS OLIGONUCLEOTIDE LIGANDS
#4083Arrays of memory cells individually comprising a capacitor and an elevationally-extending transistor, methods of forming a tier of an array of memory cells, and methods of forming an array of memory cells individually comprising a capacitor and an elevationally-extending transistor
#4084METHODS OF TREATING FGFR3 RELATED CONDITIONS
#4085Nanoconjugates able to cross the blood-brain barrier
#4086Nanocarriers and their processing for diagnostics and therapeutics
#4087Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide delivery
#4088Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the peripheral nervous system of a subject
#4089MULTI-TARGET MODULATION FOR TREATING FIBROSIS AND INFLAMMATORY CONDITIONS
#4090METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER
#4091RNA-directed DNA cleavage by the Cas9-crRNA complex
#4092Methods and compositions for enhancing the efficacy and specificity of single and double blunt-ended siRNA
#4093Targeted-Delivery of Small Interference RNA Against Anthrax
#4094NEW CRISPR ASSAYS
#4095HISTONE MODIFICATION AGENTS FOR CANCER TREATMENT
#4096Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
#4097Reduction of lipase activity in product formulations
#4098Modulation of BCL11A for treatment of hemoglobinopathies
#4099Method and Medicament For Inhibiting The Expression of A Given Gene
#4100Methods and compositions for modulating gene expression
#4101COMPOSITIONS AND METHODS FOR INHIBITING CELL PROLIFERATION
#4102Methods to accelerate antibody diversification
#4103COSTIMULATORY B7-H1 IN RENAL CELL CARCINOMA PATIENTS: INDICATOR OF TUMOR AGGRESSIVENESS AND POTENTIAL THERAPEUTIC TARGET
#4104HIV pre-immunization and immunotherapy
#4105MONOAMINE OXIDASE INHIBITORS AND METHODS FOR TREATMENT AND DIAGNOSIS OF PROSTATE CANCER
#4106USE OF EXOSOMES FOR THE TREATMENT OF DISEASE
#4107Composition
#4108Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
#4109siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
#4110Use of phospholipid scramblase inhibitors for modulating inflammatory immune responses
#4111DIBLOCK COPOLYMERS AND POLYNUCLEOTIDE COMPLEXES THEREOF FOR DELIVERY INTO CELLS
#4112Ionizable cationic lipid for RNA delivery
#4113Self-assembled ribonucleoprotein nanoparticles
#4114Carrier nanoparticles and related compositions, methods and systems
#4115METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS
#4116COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#4117Dual assembly nanoparticles
#4118Lipid-derived neutral nanoparticles
#4119Lipid-derived neutral nanoparticles
#4120Methods for treatment of metastatic thyroid cancer using a PDGFR-α inhibitor
#4121Breast cancer biomarkers and methods of using same
#4122Gene expression in Bacteroides
#4123Sortilin 1 is a novel inducer of vascular calcification
#4124Compositions and methods for controlling vasculature
#4125Method for treatment of subjects with TUG1 gene expressing brain tumor
#4126In vivo production of small interfering RNAs that mediate gene silencing
#4127Compositions and methods for delivery of a polynucleotide into a plant
#4128TRIM11 for degradation of protein aggregates
#4129Methods and compositions for nucleic acid and protein payload delivery
#4130Compositions and methods for transport across the blood brain barrier
#4131CITRIN INHIBITORS FOR THE TREATMENT OF CANCER
#4132SCREENING METHODS FOR TARGETS FOR CANCER THERAPY
#4133Compositions and methods to control insect pests
#4134RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
#4135CANCER TARGETS AND USES THEREOF
#4136METHOD FOR MAINTAINING INCREASED INTRACELLULAR p53 LEVEL, INDUCED BY PLATINUM-BASED ANTICANCER DRUG, AND APPLICATION THEREOF
#4137ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES
#4138METHODS FOR TREATING AND ASSESSING TUMOR INVASION AND METASTASIS
#4139Down-regulating gene expression in insect plants
#4140RNAi inhibition of alpha-ENaC expression
#4141UNA oligomers and compositions for treating amyloidosis
#4142Chemical modification of short small hairpin RNAs for inhibition of gene expression
#4143Dual Targeting siRNA Agents
#4144Natural antisense and non-coding RNA transcripts as drug targets
#4145Inhibition of lncRNA HOTAIR and related materials and methods
#4146Compounds and methods for increasing antisense activity
#4147CARBON MATERIAL DELIVERY SYSTEMS AND METHODS
#4148Methods and compositions for the activation of gamma-delta T-cells
#4149Methods and compositions for the activation of gamma-delta T-cells
#4150Controlling fungal pathogens by disabling their small RNA pathways using RNAi-based strategy
#4151MODULATION OF ANGIOPOIETIN-LIKE 3 EXPRESSION
#4152Method of regulating gene expression
#4153Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells
#4154Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
#4155Oligodeoxy nucleotide for preparing drugs for inhibiting tumor growth and application thereof
#4156METHODS FOR CONTROLLING PESTS USING RNAi
#4157Dynamin 2 inhibitor for the treatment of Duchenne's muscular dystrophy
#4158Targeted nanocarriers for targeted drug delivery of gene therapeutics
#4159Oligodeoxy nucleotide for preparing drugs for inhibiting tumor growth and application thereof
#4160Methods for creating a transgenic cell with microbubbles
#4161Methods for treating Parkinson's disease
#4162THREAD NUCLEIC ACID MOLECULES THAT CONFER RESISTANCE TO HEMIPTERAN PESTS
#4163Cell death inducing agent for cells having BRAF gene mutation, growth suppressing agent for same cells and pharmaceutical composition for therapy of diseases caused by growth defect of same cells
#4164Delivery of therapeutic agent
#4165COMPOSITION FOR CANCER CELL SENSITIZATION CONTAINING AS ACTIVE INGREDIENT SUBSTANCE INHIBITING EXPRESSION OF ONCOGENE OF HPV VIRUS
#4166Therapeutic oligomers for treating amyloidosis
#4167RNAi inhibitors of glucose-6-phosphate dehydrogenase for treating cardiovascular and pulmonary conditions
#4168COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS
#4169Small-interfering RNA expression systems for production of small-interfering RNAs and their use
#4170Methods and Pharmaceutical Compositions (NTSR1 Inhibitors) for the Treatment of Hepatocellular Carcinomas
#4171MicroRNA initiated DNAzyme motor operating in living cells
#4172Cytochrome B (CYTB) nucleic acid molecules that control pathogens
#4173Post-transcriptionally chemically modified double strand RNAs
#4174Therapeutics targeting IGFBP7 for the treatment or prevention of heart failure and metabolic diseases
#4175Compositions and methods for inhibiting expression of factor V
#4176SIRNA STRUCTURE FOR MINIMIZING OFF-TARGET EFFECTS AND RELAXING SATURATION OF RNAI MACHINERY AND THE USE THEREOF
#4177Anti-vascular endothelial growth factor receptor 2 (VEGFR2) antibody and methods of use thereof for detecting VEGFR2 and for inhibiting tumor growth, tumor angiogenesis and/or inducing cancer cell cytotoxicity
#4178Nucleic acid molecules containing spacers outside ITR
#4179Lipids and compositions for the delivery of therapeutics
#4180Continuously expressed therapeutic RNAs for targeted protein binding and methods for their use
#4181Negative regulator of plant immunity against nematodes
#4182Single-stranded nucleic acid molecule having delivery function and gene expression regulating ability
#4183RNA amidates and thioamidates for RNAi
#4184Methods and compositions for selecting siRNA of improved functionality
#4185Therapeutic methods, products and compositions inhibiting ZNF555
#4186Nucleoside-lipid compounds with pH-sensitive dialkylorthoester chains and their use for transportation or vectorization of at least one therapeutic agent
#4187Method of targeting senescent cells
#4188siRNA Inhibition Of Human Antigen R Expression For Treatment of Cancer
#4189Fungal immunogens and related materials and methods
#4190METHODS FOR ENHANCING AN IMMUNE RESPONSE WITH A CTLA-4 ANTAGONIST
#4191Bio-production of lentiviral vectors
#4192RNA interference-based therapeutic against anthrax
#4193Methods of inducing insulin production
#4194GENE THERAPEUTIC FOR THE TREATMENT OF HIV AND USES THEREOF
#4195Targeting hepatitis B virus (HBV) host factors
#4196Therapy
#4197Poly(β-amino ester)-co-polyethylene glycol (PEG-PBAE-PEG) polymers for gene and drug delivery
#4198Delivery of hydrophobic active agent particles
#4199METHODS AND COMPOSITIONS FOR INHIBITING THE GROWTH AND/OR PROLIFERATION OF MYC-DRIVEN TUMOR CELLS
#4200METHODS AND COMPOSITIONS FOR LOCALIZED AGENT DELIVERY